Shimizu Hideharu, Hatao Fumihiko, Imamura Kazuhiro, Takanishi Kijuro, Tsujino Motoyoshi
Department of Surgery, Tokyo Metropolitan Tama Medical Center, 2-8-29, Musashidai, Fuchu, Tokyo, Japan.
Department of Endocrinology, Tokyo Metropolitan Tama Medical Center, Fuchu, Tokyo, 183-8524, Japan.
Obes Surg. 2017 Dec;27(12):3223-3229. doi: 10.1007/s11695-017-2756-9.
Laparoscopic sleeve gastrectomy (LSG) has wide-ranging positive effects on adipocytokine metabolism, bile acid profile, and chronic low-grade inflammation related to obesity. However, the early temporal changes in these markers following LSG have not been well investigated. This study aimed to evaluate the early effects of LSG on adipocytokines, bile acid profile, and inflammatory markers.
This was a nonrandomized prospective study examining morbidly obese Japanese patients undergoing LSG. Serial measurements of leptin, adiponectin, bile acids, fibroblast growth factor (FGF)-19, and inflammatory markers were performed preoperatively and 1 and 6 months after LSG.
The study included ten patients (five females) with a mean age of 48.8 years and BMI 40.9 kg/m. At baseline, 90% of the patients had T2DM, 70% had dyslipidemia, and 90% had hypertension. Patients lost 5.1 kg/m BMI at 1 month and 10.1 kg/m BMI at 6 months. The leptin levels sharply decreased, and FGF-19 increased significantly as early as 1 month postoperatively. Adiponectin levels showed an increasing trend at 1 month and a significant increase at 6 months. A significant decrease in high-sensitivity CRP and plasminogen activator inhibitor-1 was observed at 6 months. No significant changes were observed in interleukin (IL)-6, IL-8, tumor necrosis factor-α, serum amyloid A protein, or monocyte chemotactic protein-1 throughout the study.
LSG improved the secretion of adipocytokines, increased FGF-19 secretion soon after surgery, and slowly ameliorated inflammation related to obesity through significant weight loss.
腹腔镜袖状胃切除术(LSG)对脂肪细胞因子代谢、胆汁酸谱以及与肥胖相关的慢性低度炎症具有广泛的积极影响。然而,LSG术后这些指标的早期时间变化尚未得到充分研究。本研究旨在评估LSG对脂肪细胞因子、胆汁酸谱和炎症标志物的早期影响。
这是一项非随机前瞻性研究,对接受LSG的病态肥胖日本患者进行检查。在术前以及LSG术后1个月和6个月对瘦素、脂联素、胆汁酸、成纤维细胞生长因子(FGF)-19和炎症标志物进行系列测量。
该研究纳入了10名患者(5名女性),平均年龄48.8岁,体重指数为40.9kg/m²。基线时,90%的患者患有2型糖尿病,70%患有血脂异常,90%患有高血压。患者在术后1个月体重指数下降5.1kg/m²,6个月时下降10.1kg/m²。瘦素水平在术后1个月时急剧下降,FGF-19在术后1个月时就显著升高。脂联素水平在术后1个月呈上升趋势,在6个月时显著升高。在术后6个月时观察到高敏CRP和纤溶酶原激活物抑制剂-1显著下降。在整个研究过程中,白细胞介素(IL)-6、IL-8、肿瘤坏死因子-α、血清淀粉样蛋白A或单核细胞趋化蛋白-1均未观察到显著变化。
LSG改善了脂肪细胞因子的分泌,术后不久FGF-19分泌增加,并通过显著的体重减轻缓慢改善与肥胖相关的炎症。